|
As part of the boombox post-market clinical trial, patient id (b)(6), died due to what the treating physician believes to be a thromboembolic event possibly related to the histotripsy device and histotripsy procedure performed on (b)(6) 2025.An 87 year old male patient with a history of sigmoid colon cancer, which had been resected 4 years prior, received histotripsy treatment on (b)(6) 2025 to 2 lesions in segments v (x=25 mm, y=30 mm, z = 30 mm, ptv = 29.3 cc) and vi (x=18 mm, y=22 mm, z = 14.5 mm, ptv = 11.5 cc) for a total planned treatment volume (ptv) 40.8 cc.Per the treating physician, no anti-coagulation therapy was provided prior to the histotripsy procedure.The patient had previously undergone sbrt in (b)(6) 2023, which potentially overlapped with the histotripsy ptvs.During the intraoperative course, two system errors occurred which required a system reset resulting in a cumulative delay of approximately 30 minutes.The total procedure time under anesthesia was approximately 3.5 hours.Per the treating physician, the patient's immediate post procedure recovery was uneventful.He exhibited normal neurological function, was alert, ambulating, and able to tolerate oral intake.He was transferred to the post-anesthesia care unit (pacu) in stable condition with plans for postoperative imaging, including a ct scan.While being transported for imaging, the patient suffered a cardiac arrest.Resuscitation efforts were extensive, involving 30 minutes of cardiopulmonary resuscitation (cpr) and the administration of thrombolytic therapy.Return of spontaneous circulation was achieved; however, the patient subsequently developed acute respiratory distress syndrome (ards).The patient then experienced refractory metabolic acidosis.Despite aggressive critical care interventions, the patient showed no signs of recovering, and following discussions with the family, life-sustaining treatments were withdrawn.The patient was pronounced deceased on (b)(6) 2025.A transthoracic echocardiogram performed during the resuscitation period demonstrated preserved cardiac function.No postoperative imaging was obtained.It was noted that the patient had no history of arrhythmia.For trial purposes, the event was classified by the treating physician as possibly related to the device and possibly related to the procedure.Per the treating physician, the most probable contributing factors were perioperative immobility and the absence of heparin prophylaxis.Given the patient's clinical course and known risks, this event was considered anticipated.This mdr is being submitted out of an abundance of caution due to the patient's death post-procedure although no definitive cause of death was determined.No other device malfunctions or other noteworthy events occurred during the case.
|